De La Salle Medical and Health Sciences Institute, Dasmariñas, Cavite, The Philippines.
Int J Tuberc Lung Dis. 2022 Aug 1;26(8):760-765. doi: 10.5588/ijtld.21.0632.
We conducted a feasibility and acceptability study of video-observed therapy (VOT) among patients with multidrug-resistant TB (MDR-TB) and other types of drug-resistant TB (DR-TB) in the Philippines. Patients aged ≥13 years were approached to use VOT. A smartphone with VOT mobile application to video-record medication intake was provided. Healthcare workers (HCWs) monitored adherence by watching videos via a web-based dashboard. Good adherence was defined as intake of >90% of expected doses. Feasibility and acceptability were assessed using a semi-structured questionnaire on a Likert scale. Of 308 patients, 110 (36%) patients chose VOT; 67 completed treatment using VOT and 43 stopped VOT prior to treatment outcome; 74/110 (67%) had good adherence. The treatment success rate was 88% and the loss to follow-up rate was 8.1%. Among HCWs, 90% (9/10) had a positive perception of VOT. All HCWs agreed that VOT data accurately reflect medication intake of the patients; 88/89 (99%) mentioned benefits of VOT, notably convenience, sense of comfort, privacy and security. VOT is feasible and acceptable for both patients and HCWs. This study could provide guidance to the country programme to launch VOT for treatment of patients with MDR-TB and other DR-TB.
我们在菲律宾对耐多药结核病(MDR-TB)和其他类型耐药结核病(DR-TB)患者开展了视频观察治疗(VOT)的可行性和可接受性研究。我们邀请年龄≥13 岁的患者使用 VOT。为患者提供了带有 VOT 移动应用程序的智能手机,以便视频记录药物摄入情况。医护人员(HCWs)通过基于网络的仪表板观看视频来监测患者的依从性。良好的依从性定义为摄入的预期剂量>90%。采用李克特量表的半结构式问卷评估可行性和可接受性。在 308 名患者中,有 110 名(36%)患者选择了 VOT;67 名患者使用 VOT 完成了治疗,43 名患者在治疗结果前停止了 VOT;110 名患者中有 74 名(67%)具有良好的依从性。治疗成功率为 88%,失访率为 8.1%。在 HCWs 中,有 90%(9/10)对 VOT 持积极看法。所有 HCWs 均认为 VOT 数据准确反映了患者的药物摄入情况;88/89(99%)名 HCWs 提到了 VOT 的好处,特别是方便、舒适感、隐私和安全性。VOT 对患者和 HCWs 来说都是可行且可接受的。这项研究可为该国启动 VOT 治疗 MDR-TB 和其他 DR-TB 患者提供指导。